Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Rigel Refuels R&D in $130M Offering
Rigel Refuels R&D in $130M Offering
Rigel Refuels R&D in $130M Offering
Submitted by
admin
on May 29, 2011 - 12:47pm
Source:
Seeking Alpha
News Tags:
Rigel
fostamatinib
rheumatoid arthritis
AstraZeneca
R343
asthma
Headline:
Rigel Refuels R&D in $130M Offering
Do Not Allow Advertisers to Use My Personal information
